Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
27.70
+0.70 (2.59%)
Nov 22, 2024, 4:00 PM EST - Market closed
Spyre Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,626 | 775 | 28 | 234 | 377 | 221 | |
| Market Cap Growth | 2920.19% | 2701.10% | -88.19% | -37.90% | 70.36% | 23.39% | |
| Enterprise Value | 1,368 | 959 | -41 | 127 | 243 | 138 | |
| Last Close Price | 27.70 | 21.52 | 11.25 | 118.75 | 196.75 | 191.00 | |
| PS Ratio | - | 874.91 | 11.88 | 12.50 | - | - | |
| PB Ratio | 8.30 | 4.21 | 0.55 | 2.79 | 2.70 | 3.69 | |
| P/TBV Ratio | 8.73 | - | 0.55 | 2.79 | 2.70 | 3.69 | |
| EV/Sales Ratio | - | 1082.03 | - | 6.78 | - | - | |
| Debt / Equity Ratio | - | - | 0.09 | 0.07 | 0.04 | 0.09 | |
| Asset Turnover | - | 0.00 | 0.03 | 0.14 | - | - | |
| Quick Ratio | 7.23 | 10.61 | 3.83 | 4.66 | 8.90 | 3.92 | |
| Current Ratio | 7.32 | 10.68 | 4.25 | 4.91 | 9.11 | 4.06 | |
| Return on Equity (ROE) | -91.62% | -289.17% | -124.87% | -58.81% | -80.93% | -122.74% | |
| Return on Assets (ROA) | -38.81% | -35.60% | -58.53% | -30.22% | -41.61% | -62.40% | |
| Return on Capital (ROIC) | -51.98% | -61.52% | -73.41% | -34.95% | -48.37% | -75.71% | |
| Earnings Yield | -13.22% | -43.71% | -302.87% | -28.09% | -21.44% | -35.34% | |
| FCF Yield | -9.30% | -12.89% | -289.74% | -23.17% | -21.22% | -30.34% | |
| Buyback Yield / Dilution | -845.79% | -104.59% | -28.19% | -23.18% | -67.05% | -53.44% | |
| Total Shareholder Return | -845.79% | -104.59% | -28.19% | -23.18% | -67.05% | -53.44% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.